CSL Seqirus Manufacturing

One of the largest influenza vaccine companies in the world, CSL Seqirus operates state-of-the-art manufacturing facilities in three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to customers around the world. We have one of the most comprehensive influenza vaccine portfolios in the industry, tailored to the needs of health care professionals and their patients.

CSL Seqirus utilises both egg and cell-based production technologies to produce influenza vaccine. The year-round production of seasonal influenza vaccine for both northern and southern hemispheres, enables us to be in a constant state of readiness to respond to a pandemic emergency.

With extensive research and production expertise and manufacturing plants in the US, UK and Australia, CSL Seqirus is a transcontinental partner in pandemic preparedness and plays a major role in the prevention and control of influenza globally. It’s a role we are proud of and take very seriously.

As part of our heritage, in Australia CSL Seqirus plays a unique public health role, continuing a long legacy as the manufacturer and sole supplier of a range of products made for the Australian Government in the National Interest, including snake and spider antivenoms and Q fever vaccine.